par Adès, Lionel;Boehrer, S;Prebet, Thomas;Beyne-Rauzy, Odile;Legros, Laurence;Ravoet, Christophe;Dreyfus, François;Stamatoullas, Aspasia;Chaury, Marie Pierre;Delaunay, Jacques;Laurent, Gauthier ;Vey, Norbert;Burcheri, Sara;Mbida, Rose-Marie;Hoarau, Natacha;Gardin, C;Fenaux, Pierre
Référence Blood, 113, 17, page (3947-3952)
Publication Publié, 2009-04
Référence Blood, 113, 17, page (3947-3952)
Publication Publié, 2009-04
Article révisé par les pairs
Titre: |
|
Auteur: | Adès, Lionel; Boehrer, S; Prebet, Thomas; Beyne-Rauzy, Odile; Legros, Laurence; Ravoet, Christophe; Dreyfus, François; Stamatoullas, Aspasia; Chaury, Marie Pierre; Delaunay, Jacques; Laurent, Gauthier; Vey, Norbert; Burcheri, Sara; Mbida, Rose-Marie; Hoarau, Natacha; Gardin, C; Fenaux, Pierre |
Informations sur la publication: | Blood, 113, 17, page (3947-3952) |
Statut de publication: | Publié, 2009-04 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Chromosome Deletion | |
Chromosomes, Human -- genetics | |
Female | |
Humans | |
Male | |
Middle Aged | |
Myelodysplastic Syndromes -- drug therapy -- genetics -- pathology | |
Prognosis | |
Risk Factors | |
Survival Rate | |
Thalidomide -- adverse effects -- analogs & derivatives -- pharmacology -- therapeutic use | |
Treatment Outcome | |
Note générale: | Clinical Trial, Phase II |
Journal Article | |
Langue: | Anglais |
Identificateurs: | urn:issn:0006-4971 |
info:doi/10.1182/blood-2008-08-175778 | |
info:pii/blood-2008-08-175778 | |
info:pmid/18987358 |